Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial
A pharmacist can advise whether a label-directed OTC product fits your health and medicines
Not always as dramatic as injection results, but meaningful enough to warrant the approach for patients who refuse or cannot tolerate injections
Patients should consult with licensed healthcare providers about their treatment options and ensure that any supplier they choose complies with relevant regulatory requirements
That matters because trial participants are screened and monitored differently from people using medicines in routine care
This commitment to excellence extends across our entire catalog, from foundational peptides like BPC-157 to more specialized compounds for neurological or metabolic studies
